Back

Endovia shares surge 47.83% after CannEpil funding closes

Verifying
  • Endovia closed the first funding tranche from C/M Capital Master Fund, LP.
  • Shares rose 47.83% to $0.34 in Tuesday after-hours trading.
  • CannEpil’s veterinary program targets cancer pain in companion animals, beginning with canine oncology.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.